Results 131 to 140 of about 4,731 (194)

NPC1L1 identified as a novel HCV entry factor [PDF]

Nature Reviews Gastroenterology & Hepatology, 2012
openaire   +1 more source

Long-Term Sucralose Consumption Alters Gut Microbiota and Hepatic Lipid Metabolism and Increases Depressive-like Behavior in Young Mice. [PDF]

Nutrients
Ortutu BF, Keum KS, Kim JG, Yoon SI, Cho JA.   +4 more
europepmc   +1 more source

Mechanisms of Cell Uptake and Transport of Xanthophylls in the Caco-2 Cell Model. [PDF]

Nutrients
Wu F, Chen N, Peng Y, Li M, Ni Y, Li T, Liu R, Wen X.   +7 more
europepmc   +1 more source

Reply: Genetic Variation in NPC1L1 and Risk of Gallstone Disease.

Journal of the American College of Cardiology, 2015
Ference, Brian A., Penumetcha, Raju
openaire   +2 more sources

Mechanistic Insights into <i>Lactobacillus harbinensis</i> and Other Probiotics Regulating Lipid Metabolism in T2DM Mice via the PPARγ-LXRα-NPC1L1 Signaling Pathway Based on Multi-Omics Analysis. [PDF]

Metabolites
Yeerjiang B, Manaer T, Liu X, Bieerdimulati R, Nabi X.   +4 more
europepmc   +1 more source

PPAR ALPHA-MEDIATED TRANSACTIVATION OF HUMAN NPC1L1

Abstracts of Annual meeting of Japanese Society for the Study of Xenobiotics, 2008
Takada, Tappei, Iwayanagi, Yuki, Suzuki, Hiroshi   +2 more
openaire   +1 more source

Statin-Ezetimibe Attenuates Hepatic Inflammation and Fibrosis in a Diet- and Toxin-Induced Steatohepatitis Model, Associated with Macrophage NF-κB Inhibition. [PDF]

Cells
Han SK, Lee JS, Park SJ, Lee MR, Yi YJ, Choi K, Baik SK, Kim MY.   +7 more
europepmc   +1 more source

Exogenous Ganglioside GM3 Attenuates Atherosclerosis via Multi-Organ Modulation of Lipid Metabolism. [PDF]

Pharmaceutics
Zhou J, Zhuang H, Sheng Q, Qiu Z, Chen Y.   +4 more
europepmc   +1 more source

The role of hepatic NPC1L1 on lipid and glucose metabolism

The role of hepatic NPC1L1 on lipid and glucose metabolism
Atherosclerotic cardiovascular diseases are threating causes of death all over the world, and the dyslipidemia and the impaired glucose metabolism have proved to be the major risk factors for atherosclerotic diseases. NPC1L1, a cholesterol transporter which is expressed in small intestine of mammals, has been known to be expressed in the liver of ...
openaire   +1 more source

Epigallocatechin gallate and lipid metabolism: intestinal fate, metabolite clusters, and regulatory mechanisms. [PDF]

Curr Res Food Sci
Fan J, Yun S, Qu Z, Liu Z, Gong Y.
europepmc   +1 more source